Wednesday, 3 November 2021

Aquaculture Vaccines Market is Anticipated to Upgrade USD 605.4 Million Revenue By 2028: Grand View Research Inc.

 Aquaculture Vaccines Market Growth & Trends

The global aquaculture vaccines market size is expected to reach USD 605.4 million by 2028, according to a new report by Grand View Research. It is expected to expand at a CAGR of 8.4% from 2021 to 2028. The advent of vaccines for fish has significantly reduced the dependency on antimicrobial agents. Vaccination programs help in protecting the animal health and livelihoods of those who work with livestock as well as aid in ensuring food security. The development of some aquaculture sectors, such as the salmon industry in Norway, wherein fish farmers in the country moved from using antibiotics to vaccines by 1994, demonstrates the potential of vaccines in reducing the dependence on veterinary medicines.

Similar to other markets, the market for aquaculture vaccines has also been significantly affected. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, low demand, growing awareness of animal to human disease transmission risks, and operational hurdles due to changing policies and restrictions.

The growing demand for aquatic animal-derived food products, such as oil, caviar, protein powders, and meat, is encouraging farmers to use vaccinations for aquaculture to gain higher profitability. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. The demand for healthy, sustainable, and high-quality meat products that have fewer or no drugs is also increasing rapidly. Thus, the need for healthy breeding of aquatic animals is increasing, which is expected to fuel the demand for aquaculture vaccines, thereby boosting the market growth.

The market for aquaculture vaccines is fairly competitive. The most notable participants in the market are Zoetis; Merck & Co., Inc.; and Elanco, along with other manufacturers of aquaculture vaccines. These players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC. This added to the company’s Pharmaq business, which is involved in fish vaccines and services.

Request a free sample copy or view report summary: Aquaculture Vaccines Market Report

Aquaculture Vaccines Market Report Highlights

  • Based on product, the inactivated vaccines segment held the largest share in 2020 owing to its high acceptance globally
  • By route of administration, the injected segment held the largest market share in 2020 owing to its easy availability
  • The bacterial application segment held the largest revenue share in 2020 owing to the high prevalence of bacterial diseases in aquatic species
  • In 2020, Europe held the largest revenue share owing to the increasing adoption of aquaculture vaccines, especially in countries such as Norway and the U.K.
  • North America held the second-largest revenue share in 2020. The key driver in this regional market is the presence of major market players, especially in the U.S.
  • Asia Pacific is expected to witness lucrative growth over the forecast period owing to the rise in aquaculture production and favorable government initiatives, especially in developing countries 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-aquaculture-vaccines-market

Aquaculture Vaccines Market Segmentation

Grand View Research has segmented the global aquaculture vaccines market report on the basis of product, route of administration, application, and region:

Aquaculture Vaccines Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Aquaculture Vaccines Route Of Administration Outlook (Revenue, USD Million, 2016 - 2028)

  • Oral
  • Injected
  • Immersion & Spray

Aquaculture Vaccines Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Bacterial
  • Viral
  • Parasitic

Aquaculture Vaccines Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Ireland
    • Eastern Europe
      • Croatia
      • Czech Republic
      • Hungary
      • Poland
      • Russia
      • Romania
      • Bulgaria
    • Asia Pacific
      • Japan
      • South Korea
      • Taiwan
      • Indonesia
      • Malaysia
      • Singapore
      • Thailand
      • Philippines
      • Vietnam
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Chile
      • Colombia
      • Peru
      • Ecuador
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • Israel
      • Egypt

List of Key Players of Aquaculture Vaccines Market

  • Zoetis
  • Phibro Animal Health Corporation
  • Elanco
  • Merck & Co., Inc.
  • KBNP
  • CAVAC
  • Kyoto Biken Laboratories, Inc.
  • Nisseiken Co., Ltd.
  • Vaxxinova International BV
  • HIPRA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

No comments:

Post a Comment

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...